DEAR DR. ROACH: I see screening tests advertised often. For $160 I can get screened for conditions that might cause stroke, ...

I see screening tests advertised often. For $160 I can get screened for conditions that might cause stroke, heart disease, ...

There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.

Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) 74th Annual Scientific Session and Expo in Chicago, March 29-31.

Transcatheter Aortic Valve Replacement Market outlook through 2035, highlighting key trends, growth drivers, challenges, and future opportunities ...

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

Ounce of Prevention is a weekly column which presents recommendations for preventative services derived from The United ...

Researchers found that at five years, patients with severe aortic stenosis who were treated with either TAVR or surgery had comparable rates of all-cause mortality or disabling stroke.

Teleflex Incorporated (NYSE: TFX) has announced that its AC3 Range™ Intra-Aortic Balloon Pump (IABP) has received FDA 510(k) ...

The benefits of early TAVR for patients with asymptomatic, severe aortic stenosis are consistent regardless of NT-proBNP or ...

Teleflex (NYSE: TFX) announced today that it received FDA 510(k) clearance for its AC Range intra-aortic balloon pump (IABP).

WAYNE, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- (NYSE: TFX), a leading global provider of medical technologies, today announced FDA 510(k) clearance of the AC3 Range™ Intra-Aortic Balloon ...